triple action glp 1 The “Triple G” has entered the lab. 🧬🔬 While the world is still catching up to dual-agonists, the research community is looking at the next evolution: Retatrutide. 🧪 Known as the “Triple The complete solution for natural metabolic support Toniiq GLP-1 Support — with

The drug was used in a double-blind, randomised, placebo-controlled trial including 526 adult participants with type 2 diabetes across China, India, Japan, Mexico, and the United States

29 GIP Agonism as a Potential Therapeutic Approach for Atherosclerotic Cardiovascular Disease The cardioprotective actions of incretin-based agents, particularly the GLP-1RAs, have a bulk of supporting evidence in the form of clinical studies

Always consult a qualified healthcare professional before starting or stopping any supplement

The authors also noted that more research is required to understand the full impact of GLP-1 drugs on pregnancy and fetal development